Alice Laroni

Ospedale Policlinico San Martino — Italy

Medicine · Health Sciences

37h-index4.8kcitations112works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(69), Polyomavirus and related diseases(23), Peripheral Neuropathies and Disorders(20), Immune Cell Function and Interaction(15), SARS-CoV-2 and COVID-19 Research(14)

Publications106 total

Immunosenescence in multiple sclerosis: New insights and clinical implications
Multiple Sclerosis Journal·2025
Butyrate enhances CD56bright NK cell-driven killing of activated T cells and modulates NK cell chromatin accessibility
Genes and Immunity·2025· 2 cited
Butyrate modulates the epigenetic landscape of human natural killer cells and affects their regulatory function
2024Open Access
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder
Multiple Sclerosis Journal·2024· 1 citedOpen Access
Central serous chorioretinopathy in multiple sclerosis and its differential diagnosis with optic neuritis: a case report
Neurological Sciences·2024
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
Journal of Neurology·2023· 2 citedOpen Access
Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review
Neurology and Therapy·2023· 6 citedOpen Access
Summary of Research: Caregiver Involvement in MS: Duty or Disruption?
Neurology and Therapy·2023· 1 citedOpen Access
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
Multiple Sclerosis and Related Disorders·2022· 7 citedOpen Access
Aging with multiple sclerosis: Clinical characterization of an elderly population, a cross-sectional study
Multiple Sclerosis and Related Disorders·2022· 3 cited
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
Human Vaccines & Immunotherapeutics·2022· 5 citedOpen Access
CD19+ B cell numbers predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
2022· 1 citedOpen Access
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Neurological Sciences·2022· 27 cited
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies
Multiple Sclerosis Journal·2022· 44 citedOpen Access
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy
EBioMedicine·2022· 82 citedOpen Access
Breakthrough SARS-CoV-2 infections in MS patients on disease modifying therapies
2022· 8 citedOpen Access
High or increasing serum NfL is predictive of impending multiple sclerosis relapses
Multiple Sclerosis and Related Disorders·2022· 59 citedOpen Access
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies
2021· 15 citedOpen Access
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study
CNS Drugs·2021· 9 cited
Caregiver Involvement in MS: Duty or Disruption?
Neurology and Therapy·2021· 10 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Antonio Uccelli(34), Maria Pia Sormani(18), Eleonora Cocco(16), Gianluigi Mancardi(15), Roberta Lanzillo(13), Pietro Annovazzi(12), Marinella Clerico(12), Cinzia Cordioli(11), Elisabetta Signoriello(11), Paola Cavalla(9), Caterina Lapucci(9), Jessica Frau(9), Irene Schiavetti(8), Carlo Pozzilli(8), Gıancarlo Comı(8), Valentina Torri Clerici(8), Matilde Inglese(8), Alessia Di Sapio(8), Giorgia Teresa Maniscalco(8), Simona Bonavita(8)